カテゴリー： QYResearch, 世界

脳梗塞治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Cerebral Infarction Therapy Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18269）・商品コード：DATA909X18269
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：96
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：New Technology
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、脳梗塞治療の世界市場について調査・分析し、脳梗塞治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（部分的前部循環梗塞（PACI）、総前部循環梗塞（TACI）、後部循環梗塞（POCI））、用途別（病院、診療所、医学研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の脳梗塞治療市場動向
・主要企業別マーケットシェア
・脳梗塞治療の種類別市場規模2014-2019
（部分的前部循環梗塞（PACI）、総前部循環梗塞（TACI）、後部循環梗塞（POCI））
・脳梗塞治療の用途別市場規模2014-2019
（病院、診療所、医学研究機関）
・脳梗塞治療の北米市場：主要企業・種類別/用途別市場規模
・脳梗塞治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・脳梗塞治療の中国市場：主要企業・種類別/用途別市場規模
・脳梗塞治療の日本国内市場：主要企業・種類別/用途別市場規模
・脳梗塞治療の東南アジア市場：主要企業・種類別/用途別市場規模
・脳梗塞治療のインド市場：主要企業・種類別/用途別市場規模
・脳梗塞治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Daiichi Sankyo、Johnson＆Johnson、Aprogen、Baxter、Otsuka、Mitsubishi Chemical Holdings Corporation、Nordmark、Takeda、Sanofi、Bristol-Myers Squibb、Kanion Pharmaceutical）
・脳梗塞治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Cerebral infarction is a chronic and life-threatening disease.Cerebral infarction is one of the most important types of ischemic stroke in which blood enters the brain due to the development of blockages or clots in blood vessels.It is important to emphasize that cerebral infarction is different from cerebral hemorrhage.The chance of death is high because of the sudden onset of the disease.In 2018, the global Cerebral Infarction Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cerebral Infarction Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cerebral Infarction Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Daiichi Sankyo
Johnson＆Johnson
Aprogen
Baxter
Otsuka
Mitsubishi Chemical Holdings Corporation
Nordmark
Takeda
Sanofi
Bristol-Myers Squibb
Kanion Pharmaceutical

Market segment by Type, the product can be split into
Partial Anterior Circulation Infarct (PACI)
Total Anterior Circulation Infarct (TACI)
Posterior Circulation Infarct (POCI)

Market segment by Application, split into
Hospital
Clinic
Medical Research Organization

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cerebral Infarction Therapy status, future forecast, growth opportunity, key market and key players.
To present the Cerebral Infarction Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cerebral Infarction Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cerebral Infarction Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Partial Anterior Circulation Infarct (PACI)
1.4.3 Total Anterior Circulation Infarct (TACI)
1.4.4 Posterior Circulation Infarct (POCI)
1.5 Market by Application
1.5.1 Global Cerebral Infarction Therapy Market Share by Application (2017-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Research Organization
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Cerebral Infarction Therapy Market Size
2.2 Cerebral Infarction Therapy Growth Trends by Regions
2.2.1 Cerebral Infarction Therapy Market Size by Regions (2019-2025)
2.2.2 Cerebral Infarction Therapy Market Share by Regions (2017-2015)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Key Players
3.1 Cerebral Infarction Therapy Revenue by Players (2018-2019)
3.2 Cerebral Infarction Therapy Key Players Head office and Area Served
3.3 Key Players Cerebral Infarction Therapy Product/Solution/Service
3.4 Date of Enter into Cerebral Infarction Therapy Market
3.5 Key Players Cerebral Infarction Therapy Funding/Investment Analysis
3.6 Global Key Players Cerebral Infarction Therapy Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cerebral Infarction Therapy Market Size by Type (2017-2025)
4.2 Global Cerebral Infarction Therapy Market Size by Application (2017-2025)

5 North America
5.1 North America Cerebral Infarction Therapy Market Forecast (2017-2025)
5.2 Cerebral Infarction Therapy Key Players in North America
5.3 North America Cerebral Infarction Therapy Market Size by Type
5.4 North America Cerebral Infarction Therapy Market Size by Application

6 Europe
6.1 Europe Cerebral Infarction Therapy Market Forecast (2017-2025)
6.2 Cerebral Infarction Therapy Key Players in Europe
6.3 Europe Cerebral Infarction Therapy Market Size by Type
6.4 Europe Cerebral Infarction Therapy Market Size by Application

7 China
7.1 China Cerebral Infarction Therapy Market Forecast (2017-2025)
7.2 Cerebral Infarction Therapy Key Players in China
7.3 China Cerebral Infarction Therapy Market Size by Type
7.4 China Cerebral Infarction Therapy Market Size by Application

8 Japan
8.1 Japan Cerebral Infarction Therapy Market Forecast (2017-2025)
8.2 Cerebral Infarction Therapy Key Players in Japan
8.3 Japan Cerebral Infarction Therapy Market Size by Type
8.4 Japan Cerebral Infarction Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cerebral Infarction Therapy Market Forecast (2017-2025)
9.2 Cerebral Infarction Therapy Key Players in Southeast Asia
9.3 Southeast Asia Cerebral Infarction Therapy Market Size by Type
9.4 Southeast Asia Cerebral Infarction Therapy Market Size by Application

10 India
10.1 India Cerebral Infarction Therapy Market Forecast (2017-2025)
10.2 Cerebral Infarction Therapy Key Players in India
10.3 India Cerebral Infarction Therapy Market Size by Type
10.4 India Cerebral Infarction Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Cerebral Infarction Therapy Market Forecast (2017-2025)
11.2 Cerebral Infarction Therapy Key Players in Central & South America
11.3 Central & South America Cerebral Infarction Therapy Market Size by Type
11.4 Central & South America Cerebral Infarction Therapy Market Size by Application

12 International Players Profiles
12.1 Daiichi Sankyo
12.1.1 Daiichi Sankyo Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cerebral Infarction Therapy Introduction
12.1.4 Daiichi Sankyo Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.1.5 Daiichi Sankyo Recent Development
12.2 Johnson＆Johnson
12.2.1 Johnson＆Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cerebral Infarction Therapy Introduction
12.2.4 Johnson＆Johnson Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.2.5 Johnson＆Johnson Recent Development
12.3 Aprogen
12.3.1 Aprogen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cerebral Infarction Therapy Introduction
12.3.4 Aprogen Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.3.5 Aprogen Recent Development
12.4 Baxter
12.4.1 Baxter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cerebral Infarction Therapy Introduction
12.4.4 Baxter Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.4.5 Baxter Recent Development
12.5 Otsuka
12.5.1 Otsuka Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cerebral Infarction Therapy Introduction
12.5.4 Otsuka Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.5.5 Otsuka Recent Development
12.6 Mitsubishi Chemical Holdings Corporation
12.6.1 Mitsubishi Chemical Holdings Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cerebral Infarction Therapy Introduction
12.6.4 Mitsubishi Chemical Holdings Corporation Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.6.5 Mitsubishi Chemical Holdings Corporation Recent Development
12.7 Nordmark
12.7.1 Nordmark Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cerebral Infarction Therapy Introduction
12.7.4 Nordmark Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.7.5 Nordmark Recent Development
12.8 Takeda
12.8.1 Takeda Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cerebral Infarction Therapy Introduction
12.8.4 Takeda Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.8.5 Takeda Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cerebral Infarction Therapy Introduction
12.9.4 Sanofi Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.9.5 Sanofi Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cerebral Infarction Therapy Introduction
12.10.4 Bristol-Myers Squibb Revenue in Cerebral Infarction Therapy Business (2018-2019))
12.10.5 Bristol-Myers Squibb Recent Development
12.11 Kanion Pharmaceutical

13 Market Dynamics
13.1 Drivers
13.2 Challenges
13.3 Porter’s Five Forces Analysis
13.4 Market Ecosystem and Value Chain Analysis

14 Key Findings in This Report

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Cerebral Infarction Therapy Key Market Segments
Table Key Players Cerebral Infarction Therapy Covered
Table Global Cerebral Infarction Therapy Market Size Growth Rate by Type 2019-2025 (Million US$)
Figuer Partial Anterior Circulation Infarct (PACI) Figures
Table Key Players of Partial Anterior Circulation Infarct (PACI)
Figuer Total Anterior Circulation Infarct (TACI) Figures
Table Key Players of Total Anterior Circulation Infarct (TACI)
Figuer Posterior Circulation Infarct (POCI) Figures
Table Key Players of Posterior Circulation Infarct (POCI)
Table Global Cerebral Infarction Therapy Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Cerebral Infarction Therapy Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Medical Research Organization Case Studies
Figure Cerebral Infarction Therapy Report Years Considered
Figure Global Cerebral Infarction Therapy and Growth Rate 2017-2025 (Million US$)
Table Global Cerebral Infarction Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Cerebral Infarction Therapy Market Size by Regions 2017-2025 (Million US$)
Table Global Cerebral Infarction Therapy Market Share by Regions 2017-2025
Figure Global Cerebral Infarction Therapy Market Share by Regions 2017-2025
Table Market Top Trends
Table Market Use Cases
Table Global Cerebral Infarction Therapy Revenue by by Players (2018-2019) (Million US$)
Table Global Cerebral Infarction Therapy Market Share by Players (2018-2019)
Figure Global Cerebral Infarction Therapy Market Share by by Players in 2018
Table Key Players Head office and Area Served
Table Key Players Cerebral Infarction Therapy Product/Solution/Service
Table Date of Enter into Cerebral Infarction Therapy Market
Table Global Key Players Cerebral Infarction Therapy Funding/Investment Analysis (Million USD)
Table Global Key Players Cerebral Infarction Therapy Valuation & Market Capitalization (Million USD)
Table Mergers & Acquisitions, Expansion Plans
Table Global Cerebral Infarction Therapy Market Size by Type (2017-2025) (Million US$)
Table Global Cerebral Infarction Therapy Market Size Share by Type (2017-2025)
Figure Global Cerebral Infarction Therapy Market Size Market Share by Type (2017-2025)
Table Global Cerebral Infarction Therapy Market Size by Application (2017-2025) (Million US$)
Table Global Cerebral Infarction Therapy Market Size Share by Application (2017-2025)
Figure Global Cerebral Infarction Therapy Market Size Market Share by Application (2017-2025)
Figure Global Cerebral Infarction Therapy Revenue Market Share by Application in 2018
Figure North America Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table North America Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table North America Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table North America Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table North America Cerebral Infarction Therapy Market Share by Type 2017-2025
Table North America Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table North America Cerebral Infarction Therapy Market Share by Application 2017-2025
Figure Europe Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table Europe Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table Europe Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table Europe Cerebral Infarction Therapy Market Share by Type 2017-2025
Table Europe Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table Europe Cerebral Infarction Therapy Market Share by Application 2017-2025
Figure China Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table China Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table China Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table China Cerebral Infarction Therapy Market Share by Type 2017-2025
Table China Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table China Cerebral Infarction Therapy Market Share by Application 2017-2025
Figure Japan Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table Japan Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table Japan Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table Japan Cerebral Infarction Therapy Market Share by Type 2017-2025
Table Japan Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table Japan Cerebral Infarction Therapy Market Share by Application 2017-2025
Figure Southeast Asia Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table Southeast Asia Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table Southeast Asia Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table Southeast Asia Cerebral Infarction Therapy Market Share by Type 2017-2025
Table Southeast Asia Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table Southeast Asia Cerebral Infarction Therapy Market Share by Application 2017-2025
Figure India Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table India Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table India Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table India Cerebral Infarction Therapy Market Share by Type 2017-2025
Table India Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table India Cerebral Infarction Therapy Market Share by Application 2017-2025
Figure Central & South America Cerebral Infarction Therapy Market Size 2017-2025 (Million US$)
Table Central & South America Key Players Cerebral Infarction Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cerebral Infarction Therapy Market Share (2018-2019)
Table Central & South America Cerebral Infarction Therapy Market Size by Type 2017-2025 (Million US$)
Table Central & South America Cerebral Infarction Therapy Market Share by Type 2017-2025
Table Central & South America Cerebral Infarction Therapy Market Size by Application 2017-2025 (Million US$)
Table Central & South America Cerebral Infarction Therapy Market Share by Application 2017-2025
Table Daiichi Sankyo Company Details
Table Company Description and Business Overview
Table Daiichi Sankyo Cerebral Infarction Therapy Product
Table Daiichi Sankyo Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Daiichi Sankyo Recent Development
Table Johnson＆Johnson Company Details
Table Company Description and Business Overview
Table Johnson＆Johnson Cerebral Infarction Therapy Product
Table Johnson＆Johnson Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Johnson＆Johnson Recent Development
Table Aprogen Company Details
Table Company Description and Business Overview
Table Aprogen Cerebral Infarction Therapy Product
Table Aprogen Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Aprogen Recent Development
Table Baxter Company Details
Table Company Description and Business Overview
Table Baxter Cerebral Infarction Therapy Product
Table Baxter Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Baxter Recent Development
Table Otsuka Company Details
Table Company Description and Business Overview
Table Otsuka Cerebral Infarction Therapy Product
Table Otsuka Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Otsuka Recent Development
Table Mitsubishi Chemical Holdings Corporation Company Details
Table Company Description and Business Overview
Table Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Product
Table Mitsubishi Chemical Holdings Corporation Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Mitsubishi Chemical Holdings Corporation Recent Development
Table Nordmark Company Details
Table Company Description and Business Overview
Table Nordmark Cerebral Infarction Therapy Product
Table Nordmark Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Nordmark Recent Development
Table Takeda Company Details
Table Company Description and Business Overview
Table Takeda Cerebral Infarction Therapy Product
Table Takeda Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Takeda Recent Development
Table Sanofi Company Details
Table Company Description and Business Overview
Table Sanofi Cerebral Infarction Therapy Product
Table Sanofi Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Details
Table Company Description and Business Overview
Table Bristol-Myers Squibb Cerebral Infarction Therapy Product
Table Bristol-Myers Squibb Revenue in Cerebral Infarction Therapy Business 2018 and 2019 (Million US$)
Table Bristol-Myers Squibb Recent Development
Table Kanion Pharmaceutical Company Details
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Opportunities
Table Key Challenges
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Daiichi Sankyo、Johnson＆Johnson、Aprogen、Baxter、Otsuka、Mitsubishi Chemical Holdings Corporation、Nordmark、Takeda、Sanofi、Bristol-Myers Squibb、Kanion Pharmaceutical

★調査レポート[脳梗塞治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18269)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳梗塞治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 血栓溶解療法の世界市場：規模・現状・予測2019-2025
    DATA909X19032 / QYResearch / 2019年11月25日 / ※当調査レポートでは、血栓溶解療法の世界市場について調査・分析し、血栓溶解療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル遮断、急性虚血性脳卒中）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血栓溶解療法市場動向 ・主要企業別マーケットシェア ・血栓溶解療法の種類別市場規模2014-2019 （薬物治療、外科治療、その他の治療） ・血栓溶解療法の用途別市場規模2014-2019 （急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル遮断、急性虚血性脳卒中） ・血栓溶解療法の北米市場：主要企業・種類別/用途別市場規模 ・血栓溶解療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Blood clots are one of the most serious complications in the body.When blood clots, major arteries or veins become blocked, which stops normal blood flow.The cessation of normal blood flow can cause bleeding and often leads to heart attacks and strokes.Thrombolytic therapy is a treatment in which solid blood clots are dissolved by administration of thrombolytic drugs.The length of treatment depends on the type or degree of complication.In the case of a heart attack, treatment may take up to an hour, or 48 hours in the case of a deep vein thrombosis.Brain CT test, electrocardiogram and electroencephalogram are effective methods...
  • 時差ぼけ治療アプリの世界市場：規模・現状・予測2019-2025
    DATA909X18605 / QYResearch / 2019年11月25日 / ※当調査レポートでは、時差ぼけ治療アプリの世界市場について調査・分析し、時差ぼけ治療アプリの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（Android、iOS）、用途別（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の時差ぼけ治療アプリ市場動向 ・主要企業別マーケットシェア ・時差ぼけ治療アプリの種類別市場規模2014-2019 （Android、iOS） ・時差ぼけ治療アプリの用途別市場規模2014-2019 （ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他） ・時差ぼけ治療アプリの北米市場：主要企業・種類別/用途別市場規模 ・時差ぼけ治療アプリのヨーロッパ市場：主要企業・種類別/用途別市場規模...Jet Lag Therapy APPs and gadgets were designed to prevent or cure jetlag.It uses its artificial intelligence engine to calculate a personalized in-flight plan of activities and environmental settings which can help avoid jet lag.For example, at different stages of flight, the Jet Lag Adviser will send push notifications to stay hydrated, recommend meals that could help you feel better, and recommend that you wind-things down, turn down the lights, and listen to calming music or light entertainment.In 2018, the global Jet Lag Therapy APP market size was xx million US$ and it is expected to reach xx million US$...
  • アジュバント療法の世界市場：規模・現状・予測2019-2025
    DATA909X18127 / QYResearch / 2019年11月25日 / ※当調査レポートでは、アジュバント療法の世界市場について調査・分析し、アジュバント療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、ホルモン療法、その他）、用途別（病院、医療機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアジュバント療法市場動向 ・主要企業別マーケットシェア ・アジュバント療法の種類別市場規模2014-2019 （化学療法、放射線療法、ホルモン療法、その他） ・アジュバント療法の用途別市場規模2014-2019 （病院、医療機関、その他） ・アジュバント療法の北米市場：主要企業・種類別/用途別市場規模 ・アジュバント療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal.In 2018, the global Adjuvant Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Adjuvant Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adjuvant Therapy development in North America, Europe and Asia-Pacific. The...
  • 時差ぼけ療法医薬品の世界市場：規模・現状・予測2019-2025
    DATA909X18606 / QYResearch / 2019年11月25日 / ※当調査レポートでは、時差ぼけ療法医薬品の世界市場について調査・分析し、時差ぼけ療法医薬品の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（Rx、OTC）、用途別（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の時差ぼけ療法医薬品市場動向 ・主要企業別マーケットシェア ・時差ぼけ療法医薬品の種類別市場規模2014-2019 （Rx、OTC） ・時差ぼけ療法医薬品の用途別市場規模2014-2019 （ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他） ・時差ぼけ療法医薬品の北米市場：主要企業・種類別/用途別市場規模 ・時差ぼけ療法医薬品のヨーロッパ市場：主要企業・種類別/用途別市場規模...Jet lag is a sleep disorder that occurs when the body's biological clock does not correspond to local time. This is common when traveling across different time zones.Melatonin is a natural hormone made by the body's pineal gland that helps regulate the sleep-wake cycle.In 2018, the global Jet Lag Therapy Pharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Jet Lag Therapy Pharmaceuticals status, future forecast, growth opportunity, key market and key players. The study...

    • ◆H&Iグローバルリサーチのお客様（例）◆